Clinical Trial Update: A Study of Pegasys Monotherapy in Patients With Chronic Hepatitis B Who Have Participated in Previous Studies [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating pegylated interferon alfa-2a (Pegasys) as monotherapy in adults with chronic hepatitis B who previously participated in other studies…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Pegasys (pegylated interferon alfa-2a)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Hepatitis B, Chronic | Phase 1 | Status: COMPLETED